Skip to main content

Peer Review reports

From: Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions

Original Submission
2 Dec 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
17 Jan 2024 Reviewed Reviewer Report
1 Apr 2024 Reviewed Reviewer Report - Lyudmila V. Bel'Skaya
3 Apr 2024 Reviewed Reviewer Report
15 May 2024 Author responded Author comments - Yasmine Kamal
Resubmission - Version 5
15 May 2024 Submitted Manuscript version 5
24 May 2024 Author responded Author comments - Yasmine Kamal
Resubmission - Version 6
24 May 2024 Submitted Manuscript version 6
11 Jun 2024 Reviewed Reviewer Report - Lyudmila V. Bel'Skaya
21 Jun 2024 Reviewed Reviewer Report
22 Jun 2024 Author responded Author comments - Yasmine Kamal
Resubmission - Version 7
22 Jun 2024 Submitted Manuscript version 7
25 Jun 2024 Author responded Author comments - Yasmine Kamal
Resubmission - Version 8
25 Jun 2024 Submitted Manuscript version 8
Publishing
3 Jul 2024 Editorially accepted
24 Jul 2024 Article published 10.1186/s12903-024-04569-z

You can find further information about peer review here.

Back to article page